🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Stocks

Morgan Stanley bullish on UBS stock, cites strong earnings and integration progress

EditorEmilio Ghigini
Published 12/11/2024, 10:04
UBS
-

On Tuesday, Morgan Stanley (NYSE:MS) updated its outlook on UBS AG (UBSG:SW) (NYSE: UBS) stock, increasing the bank's price target from CHF31.00 to CHF34.00, while retaining an Overweight rating.

The firm's analyst cited a positive view on the company's earnings trajectory, influenced by several factors including beneficial cyclical tailwinds and effective integration strategies.

The analyst highlighted that falling interest rates are providing a constructive environment for UBS AG across various segments, including investment banking performance, asset management, and wealth management. These conditions are expected to contribute positively to the bank's financial performance.

In addition to the favorable market conditions, Morgan Stanley's analyst praised UBS AG for its strong execution on integration processes. The financial institution has reported beating earnings expectations in the first three quarters of the year, which has reinforced the analyst's confidence in the bank's operational capabilities.

Despite the positive outlook, the analyst acknowledged that there are uncertainties regarding the bank's capital which could impact the stock's performance.

Clarity on this matter is anticipated in the first half of 2025. Due to this uncertainty, UBS AG has not been added to Morgan Stanley's most preferred list, although the Overweight rating suggests a continued favorable view of the stock's prospects.

In other recent news, UBS Group AG (NYSE:UBS) reported a strong financial performance for the third quarter of 2024, with a net profit of $1.4 billion and an underlying profit before tax (PBT) of $2.4 billion. The company's year-to-date PBT reached $7.1 billion, alongside a 9.2% return on CET1 capital.

UBS's underlying revenues saw a 9% increase year-on-year, and invested assets rose by 15%, amounting to a total of $6.2 trillion. The firm's CET1 capital ratio stood at 14.3%, following an expedited phase-out of transitional capital adjustments.

In the realm of technological advancements, UBS has been investing in tools like Microsoft (NASDAQ:MSFT) Copilot and its AI assistant, Red. The company has also completed client account migrations in Luxembourg and Hong Kong, with more planned for Singapore, Japan, and Switzerland. Despite facing global macroeconomic challenges, UBS maintains its focus on long-term growth objectives.

According to analysts, UBS aims to exceed pre-acquisition capital returns by 2026, pending regulatory assessments. It is also anticipated that the CET1 capital ratio might decrease to 13.3% in the forthcoming report.

However, the firm remains confident in achieving its long-term growth objectives, emphasizing ongoing integration efforts and fully staffed teams for client satisfaction and operational efficiency.

InvestingPro Insights

Recent data from InvestingPro adds depth to Morgan Stanley's positive outlook on UBS AG. The bank's market capitalization stands at $103.74 billion, reflecting its significant presence in the financial sector. UBS's revenue growth of 28.1% over the last twelve months as of Q3 2024 aligns with the analyst's observations about beneficial cyclical tailwinds.

InvestingPro Tips highlight UBS's strength as a "prominent player in the Capital Markets industry," which supports Morgan Stanley's confidence in the bank's performance across various segments. The stock's strong return over the last three months, with a price total return of 14.04%, corroborates the analyst's positive view on UBS's earnings trajectory.

It's worth noting that UBS is trading near its 52-week high, with the current price at 97.93% of its peak. This performance, coupled with the fact that UBS "has raised its dividend for 3 consecutive years," may appeal to investors looking for both growth and income potential.

For readers interested in a more comprehensive analysis, InvestingPro offers 7 additional tips that could provide further insights into UBS's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.